Lpath to Present Data at Arrowhead’s 3rd Annual Traumatic Brain Injury Conference on March 7, 2013

[at noodls] – SAN DIEGO, CA — (MARKETWIRE) — 02/25/13 — Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, has been invited to present data from its Lpathomabâ„¢ program in models … more

View todays social media effects on LPTN

View the latest stocks trending across Twitter. Click to view dashboard

See who Lpath is hiring next, click here to view